Peer-reviewed veterinary case report
Changes in dog poop bacteria linked to mast cell tumor signs
By Aluai-Cunha, Catarina et al.·Published in Research in veterinary science·2026·Department of Veterinary Clinics·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Linking faecal microbiota changes to clinical and prognostic features in dogs with mast cell tumours through 16S rRNA gene sequencing.
- Species:
- dog
Plain-English summary
A group of dogs with mast cell tumors (MCT), a type of skin cancer, had their fecal bacteria analyzed to see if there was a link between these bacteria and the severity of their disease. The study found that certain bacteria, like Pseudomonadota and Clostridium, were more common in dogs with worse outcomes, including shorter survival times. This suggests that the types of bacteria in a dog's gut could play a role in how aggressive their cancer is. Understanding these connections may help veterinarians make better treatment decisions for dogs with MCT.
People also search for: dog mast cell tumor prognosis · gut bacteria and dog cancer · mast cell tumor treatment options for dogs
Abstract
Mast cell tumours (MCT) represent one of the most relevant oncologic diseases in veterinary medicine, due to their high incidence, significant impact on clinical decision-making and patient outcomes. Therapeutic options remain limited, thereby reinforcing the critical need to identify additional oncogenic drivers, and a growing body of evidence has underscored the pivotal role of the microbiota in the pathogenesis and progression of neoplastic diseases. This study aimed to evaluate whether taxonomic groups identified in the faecal microbiota of dogs diagnosed with MCT are associated with clinicopathological features and patient's outcomes. Using 16S rRNA gene sequencing, the faecal microbiota was characterised in 47 dogs. Statistical and bioinformatic analyses were conducted in Python using a DADA2-based pipeline to process amplicon sequence variants (ASV). Statistical models were applied to identify taxonomic groups associated with clinicopathological and prognostic features. Increased abundance of Pseudomonadota and Clostridium sensu stricto 1 was detected in patients with lower disease-free survival (DFS) (p < 0.001; p = 0.01) and lower overall survival (OS) (p < 0.01; p < 0.01). Moreover, the class Clostridia was also more prevalent in patients with metastases (p = 0.02). Patients with grade III MCT and mitotic index ≥5 HPF had a higher predominance of Phascolarctobacterium (p = 0.03; p = 0.01). The genus Escherichia-Shigella was also significantly associated with a lower DFS (p < 0.01) and OS (p < 0.01). This study was the first to provide insight into faecal microbial profiles associated with MCT clinicopathological features and patients' prognosis in dogs and it was found that the relative abundance of certain bacterial taxa was significantly increased in individuals with more aggressive disease, particularly those taxa considered potentially pathogenic or detrimental to health.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41812341/